home / stock / lumo / lumo short
Short Information | Lumos Pharma Inc. (NASDAQ:LUMO)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 40,419 |
Total Actual Volume | 238,833 |
Short Trends | |
---|---|
Cover Days | 19 |
Short Days | 1 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 2,021 |
Average Short Percentage | 16.25% |
Is there a LUMO Short Squeeze or Breakout about to happen?
See the LUMO Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-26-2024 | $2.7436 | $2.77 | $2.78 | $2.7436 | 688 | 117 | 17.01% |
04-25-2024 | $2.7133 | $2.76 | $2.81 | $2.7133 | 1,569 | 140 | 8.92% |
04-24-2024 | $2.9 | $2.795 | $2.93 | $2.72 | 46,348 | 5,395 | 11.64% |
04-23-2024 | $2.73 | $2.8 | $2.85 | $2.7 | 17,078 | 4,906 | 28.73% |
04-22-2024 | $2.67 | $2.68 | $2.695 | $2.6 | 4,652 | 466 | 10.02% |
04-19-2024 | $2.65 | $2.59 | $2.83 | $2.53 | 12,311 | 8,379 | 68.06% |
04-18-2024 | $2.45 | $2.62 | $2.76 | $2.41 | 12,387 | 3,780 | 30.52% |
04-17-2024 | $2.45 | $2.52 | $2.56 | $2.41 | 14,403 | 447 | 3.1% |
04-16-2024 | $2.585 | $2.52 | $2.69 | $2.46 | 18,763 | 3,233 | 17.23% |
04-15-2024 | $2.42 | $2.45 | $2.57 | $2.41 | 28,476 | 2,402 | 8.44% |
04-12-2024 | $2.72 | $2.64 | $2.72 | $2.41 | 15,356 | 496 | 3.23% |
04-11-2024 | $2.79 | $2.71 | $2.8999 | $2.69 | 23,100 | 6,681 | 28.92% |
04-10-2024 | $2.69 | $2.69 | $2.69 | $2.69 | 583 | 147 | 25.21% |
04-09-2024 | $2.685 | $2.69 | $2.7719 | $2.65 | 4,262 | 418 | 9.81% |
04-08-2024 | $2.8 | $2.65 | $2.84 | $2.65 | 9,133 | 239 | 2.62% |
04-05-2024 | $2.81 | $2.74 | $2.8105 | $2.74 | 2,550 | 306 | 12% |
04-04-2024 | $2.78 | $2.78 | $2.8356 | $2.6001 | 12,271 | 1,634 | 13.32% |
04-03-2024 | $2.82 | $2.76 | $2.85 | $2.76 | 6,918 | 250 | 3.61% |
04-02-2024 | $2.79 | $2.84 | $2.84 | $2.75 | 3,462 | 139 | 4.02% |
04-01-2024 | $2.86 | $2.84 | $2.9046 | $2.7976 | 4,523 | 844 | 18.66% |
News, Short Squeeze, Breakout and More Instantly...
Lumos Pharma Inc. Company Name:
LUMO Stock Symbol:
NASDAQ Market:
AUSTIN, Texas, April 18, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate for Pediatric Growth Hormone Deficiency (PGHD) through Phase 2 clinical trials, announced today that abstracts reviewing data from its Phase ...
Lumos Pharma (NASDAQ: LUMO) , a biopharmaceutical company advancing an oral therapeutic candidate for pediatric growth hormone deficiency (“PGHD”) through phase 2 clinical trials, has received a notice of allowance for a submitted patent. The notice was received from the U.S. P...
AUSTIN, Texas, March 20, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic ca...